Informações:
Falhas:
ID
20409
Descrição
FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00724503
Link
https://clinicaltrials.gov/show/NCT00724503
Palavras-chave
Versões (1)
- 21/02/2017 21/02/2017 -
Transferido a
21 de fevereiro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Colorectal Cancer NCT00724503
Eligibility Colorectal Cancer NCT00724503
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT00724503
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Liver metastases
Item
unequivocal and measurable ct evidence of liver metastases which are not treatable by surgical resection or local ablation.
boolean
C0494165 (UMLS CUI [1])
Extra-hepatic metastases
Item
limited extra-hepatic metastases in the lung and/or lymph nodes are permitted (lung: 5 lesions total, < 1 cm, or 1 single lesion of up to 1.7 cm; lymph nodules in one single anatomic area (pelvis, abdomen or chest): any number, < 2 cm).
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C1517058 (UMLS CUI [1,2])
Organ function
Item
suitable for either treatment regimen.
boolean
C0678852 (UMLS CUI [1])
Prior chemotherapy
Item
prior chemotherapy for metastatic colorectal cancer is not allowed.
boolean
C1514457 (UMLS CUI [1])
Performance status
Item
who performance status 0-1.
boolean
C1518965 (UMLS CUI [1])
Hematological, renal and hepatic function
Item
adequate hematological, renal and hepatic function.
boolean
C0541533 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Informed consent
Item
willing and able to provide written informed consent.
boolean
C0021430 (UMLS CUI [1])
Life expectancy
Item
life expectancy of at least 3 months without any active treatment.
boolean
C0023671 (UMLS CUI [1])
Comorbidity
Item
evidence of ascites, cirrhosis, portal hypertension, main portal or venous tumor involvement or thrombosis as determined by clinical or radiologic assessment.
boolean
C0009488 (UMLS CUI [1])
Previous radiotherapy
Item
previous radiotherapy delivered to the upper abdomen.
boolean
C1522449 (UMLS CUI [1])
Non-malignant disease which interferes with study protocol
Item
non-malignant disease that would render the patient unsuitable for treatment according to the protocol.
boolean
C1513063 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
Peripheral neuropathy
Item
peripheral neuropathy > grade 1 (nci-ctc).
boolean
C0031117 (UMLS CUI [1])
Dose limiting toxicity
Item
dose limiting toxicity with previous adjuvant 5-fu or oxaliplatin chemotherapy.
boolean
C1512043 (UMLS CUI [1,1])
C0013221 (UMLS CUI [1,2])
C0013221 (UMLS CUI [1,2])
Prior non-adjuvant chemotherapy
Item
prior non-adjuvant chemotherapy for any malignancy. adjuvant chemotherapy for colorectal cancer is not an exclusion criteria provided that it was completed more than 6 months before entry into the study.
boolean
C1514457 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,3])
C1522673 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,3])
Gynaecological status
Item
pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Malignancy
Item
other active malignancy.
boolean
C0006826 (UMLS CUI [1])